Moderna Inc

NASDAQ:MRNA  
160.14
-7.38 (-4.40%)
4:01:42 PM EDT: $160.33 +0.19 (+0.12%)
Products

Moderna Announces Additional 20 Million Doses Of Covid-19 Vaccine To Covax For Supply In 2021 And New Additional Supply Agreement For 2022

Published: 12/10/2021 14:22 GMT
Moderna Inc (MRNA) - Moderna Announces Additional 20 Million Doses of Covid-19 Vaccine to Covax for Supply in 2021 and New Additional Supply Agreement for 2022.
Moderna Inc - Gavi Now Retains Option to Procure a Total of Up to 650 Million Doses in 2021 and 2022.
Moderna Inc - Total of 54 Million Doses to Be Supplied to Covax in 2021.
Moderna Inc - New 2022 Supply Agreement: 20 Million Additional Doses Purchased for Supply in Q2 for Total of 136.5 Million Doses.
Moderna Inc - Total of 54 Million Doses to Be Supplied to Covax in 2021.
Moderna Inc - Gavi Retains Option for Additional 30 Million in Q2 and 100 Million in Q3 2022.
Moderna Inc - Deliveries to Covax Advance Market Commitment (amc) Countries Have Already Begun.
Moderna Inc - Gavi Retains Option to Procure 233 Million Additional Doses in 2022 Under Original Agreement.